Efficacy and Biomarker Analysis of Neoadjuvant Disitamab Vedotin Combined with Immunotherapy in Patients with Muscle-Invasive Bladder Cancer: A Multi-Center Real-World Study.
JOURNAL OF CLINICAL ONCOLOGY（2024）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要